L Montella

Summary

Affiliation: Federico II University
Country: Italy

Publications

  1. doi request reprint Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)
    G Palmieri
    Molecular and Clinical Endocrinology and Oncology Department, University Federico II, Napoli, Italy
    Ann Oncol 21:1168-72. 2010
  2. pmc Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies
    Giovannella Palmieri
    Clinical Endocrinology and Oncology Department, UniversityFederico II, Via Pansini 5, 80128 Naples, Italy
    World J Clin Oncol 3:111-5. 2012
  3. ncbi request reprint Role of somatostatin analogs in the management of rare tumors and diseases
    G Palmieri
    Department of Molecular and Clinical Oncology and Endocrinology, Federico II University, Naples, Italy
    J Endocrinol Invest 26:89-91. 2003
  4. doi request reprint Imatinib mesylate in thymic epithelial malignancies
    Giovannella Palmieri
    Molecular and Clinical Endocrinology and Oncology Department, University Federico II, Via Pansini 5, 80128 Naples, Italy
    Cancer Chemother Pharmacol 69:309-15. 2012
  5. ncbi request reprint Somatostatin analogs and prednisone in advanced refractory thymic tumors
    Giovannella Palmieri
    Department of Molecular and Clinical Endocrinology and Oncology, University of Naples Federico II, Naples, Italy
    Cancer 94:1414-20. 2002
  6. ncbi request reprint [Thymoma and somatostatin analogs. Biology, diagnostic and clinical practice]
    G Palmieri
    Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, , Naples, Italy
    Minerva Endocrinol 26:193-5. 2001
  7. ncbi request reprint Role of somatostatin analogue-based therapy in unresponsive malignant thymomas
    G Palmieri
    Department of Molecular and Clinical Oncology and Endocrinology, University Federico II, Naples, Italy
    Ann Med 31:80-5. 1999
  8. ncbi request reprint A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients: A phase II trial
    R Addeo
    ASLNA3, Frattamaggiore, Italy Università Cattolica del Sacro Cuore, Roma, Italy S U N, Napoli, Italy
    J Clin Oncol 27:1085. 2009
  9. ncbi request reprint Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract
    G Palmieri
    Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy
    Amino Acids 32:395-400. 2007
  10. doi request reprint Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide
    L Montella
    Medical Oncology Unit, S Giovanni di Dio Hospital, Via Giovanni XXIII, Frattamaggiore, Naples, Italy
    Eur J Cancer Care (Engl) 19:200-4. 2010

Collaborators

Detail Information

Publications30

  1. doi request reprint Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)
    G Palmieri
    Molecular and Clinical Endocrinology and Oncology Department, University Federico II, Napoli, Italy
    Ann Oncol 21:1168-72. 2010
    ..We conducted a multicenter study to determine the activity and tolerability of this regimen in pretreated TETs...
  2. pmc Everolimus plus long-acting somatostatin analogs in thymic epithelial malignancies
    Giovannella Palmieri
    Clinical Endocrinology and Oncology Department, UniversityFederico II, Via Pansini 5, 80128 Naples, Italy
    World J Clin Oncol 3:111-5. 2012
    ..In this report, we show for the first time that everolimus was effective in two heavily pretreated patients with advanced TETs, with a progression-free survival longer than 1 year and minimal toxicity...
  3. ncbi request reprint Role of somatostatin analogs in the management of rare tumors and diseases
    G Palmieri
    Department of Molecular and Clinical Oncology and Endocrinology, Federico II University, Naples, Italy
    J Endocrinol Invest 26:89-91. 2003
  4. doi request reprint Imatinib mesylate in thymic epithelial malignancies
    Giovannella Palmieri
    Molecular and Clinical Endocrinology and Oncology Department, University Federico II, Via Pansini 5, 80128 Naples, Italy
    Cancer Chemother Pharmacol 69:309-15. 2012
    ....
  5. ncbi request reprint Somatostatin analogs and prednisone in advanced refractory thymic tumors
    Giovannella Palmieri
    Department of Molecular and Clinical Endocrinology and Oncology, University of Naples Federico II, Naples, Italy
    Cancer 94:1414-20. 2002
    ....
  6. ncbi request reprint [Thymoma and somatostatin analogs. Biology, diagnostic and clinical practice]
    G Palmieri
    Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, , Naples, Italy
    Minerva Endocrinol 26:193-5. 2001
    ..These data, ranging from in vivo diagnosis to treatment and the in vitro study of receptor expression, confirm that somatostatin plays a major role in thymic tumours...
  7. ncbi request reprint Role of somatostatin analogue-based therapy in unresponsive malignant thymomas
    G Palmieri
    Department of Molecular and Clinical Oncology and Endocrinology, University Federico II, Naples, Italy
    Ann Med 31:80-5. 1999
    ....
  8. ncbi request reprint A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients: A phase II trial
    R Addeo
    ASLNA3, Frattamaggiore, Italy Università Cattolica del Sacro Cuore, Roma, Italy S U N, Napoli, Italy
    J Clin Oncol 27:1085. 2009
    ..Several studies demonstrated that this drug seems to represent an active treatment for metastatic breast cancer (MCB). We evaluated the clinical efficacy and tolerance of metronomic chemotherapy with oral VNR...
  9. ncbi request reprint Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract
    G Palmieri
    Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy
    Amino Acids 32:395-400. 2007
    ....
  10. doi request reprint Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide
    L Montella
    Medical Oncology Unit, S Giovanni di Dio Hospital, Via Giovanni XXIII, Frattamaggiore, Naples, Italy
    Eur J Cancer Care (Engl) 19:200-4. 2010
    ..The reduced need for daily administration of colony-stimulating factors, blood sampling, antibiotic therapy and hospitalization has a significant impact in terms of both quality of life and pharmaco-economic evaluations...
  11. ncbi request reprint Gemcitabine-capecitabine in platinum-refractory patients with thymic epithelial tumors
    G Palmieri
    Universita Federico II, Naples, Italy Hospital Villa Maria, Mirabella Eclano, Italy I F O Regine Elena, Rome, Italy Hospital S Giovanni di Dio, Frattamaggiore, Italy
    J Clin Oncol 27:7590. 2009
    ..Additional agents are needed in this setting. We have designed a pilot study, phase II multicenter, to evaluate the efficacy and safety of no tested schedule gemcitabine-capecitabine in patients refractory to platinum based chemotherapy...
  12. pmc Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR
    M Caraglia
    Department of Biochemistry and Biophysics, Second University of Naples, Naples, Italy
    Cell Death Dis 2:e150. 2011
    ..The determination of both the oxidative stress status and pERK activity in PBMC has high value in the prediction of response to sorafenib+octreotide therapy in HCC patients...
  13. ncbi request reprint Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study
    S Del Prete
    San Giovanni di Dio Hospital, Frattamaggiore, Italy Ospedale San Gennaro ASLNA1, Napoli, Italy A O Cotugno, Napoli, Italy Ospedale Piedimonte Matese, Caserta, Italy Department of Molecular and Clinical Endocrinology and Oncology, Napoli, Italy Opsedale Castellammare Di Stabia, Napoli, Italy INT Fondazione G Pascale, Napoli, Italy
    J Clin Oncol 26:15624. 2008
    ..Sorafenib is a multikinase inhibitor with proven activity in advanced HCC. Octreotide is already used in this setting with conflicting but usually interesting results...
  14. ncbi request reprint Vascular endothelial growth factor monitoring in advanced hepatocellular carcinoma patients treated with radiofrequency ablation plus octreotide: a single center experience
    L Montella
    San Giovanni di Dio Hospital, Naples, Italy
    Oncol Rep 20:385-90. 2008
    ..Statistically significant correlation was found between serum VEGF and tumor progression. In conclusion, the combination of RFA and octreotide was active in advanced HCC, however, confirmation in a larger series is required...
  15. ncbi request reprint Mediastinal images resembling thymus following 131-I treatment for thyroid cancer
    L Montella
    Medical Oncology Department, S Giovanni di Dio Hospital, via Pirozzi, 80027 Frattaminore, Naples, Italy
    Monaldi Arch Chest Dis 63:114-7. 2005
    ..This evaluation is presented together with some hypotheses on the relationships between thymus and thyroid. Moreover, some considerations are made on the differential diagnosis between thymus and mediastinal tumour thyroid residues...
  16. ncbi request reprint B-cell lymphopenia and hypogammaglobulinemia in thymoma patients
    L Montella
    Molecular and Clinical Oncology and Endocrinology Department, Faculty of Medicine, University Federico II, Via Pansini 5, 80131, Naples, Italy
    Ann Hematol 82:343-7. 2003
    ..Therefore, immunophenotype has to be monitored in follow-up of thymoma patients because it may reveal significant abnormalities...
  17. ncbi request reprint Ultra-low-dose interleukin-2 in unresectable hepatocellular carcinoma
    Giovannella Palmieri
    Department of Molecular and Clinical Endocrinology and Oncology, University Federico II, Naples, Italy
    Am J Clin Oncol 25:224-6. 2002
    ..Low-dose IL-2 can be considered an active and well-tolerated treatment for unresectable hepatocellular carcinoma. Future studies on large numbers of patients are necessary to confirm these results...
  18. ncbi request reprint In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumors
    Tullio Florio
    National Institute for Cancer Research, Advanced Biotechnology Center, Largo Rosanna Benzi 10, 16132 Genova, Italy
    Anticancer Res 23:2465-71. 2003
    ..Previous studies showed that the subtype 2 of somatostatin receptors (sstr2) is generally expressed by soft tissue sarcomas...
  19. ncbi request reprint Clonal expansion of CD8+ BV8 T lymphocytes in bone marrow characterizes thymoma-associated B lymphopenia
    Anna Maria Masci
    Dipartimento di Biologia e Patologia Cellulare e Molecolare, Federico II University of Naples, Italy
    Blood 101:3106-8. 2003
    ..We propose that BV8 CD8(+) T cells may play a role in the pathogenesis of this immunodeficiency syndrome...
  20. ncbi request reprint Functional imaging of Langerhans cell histiocytosis by (111)In-DTPA-D-Phe(1)-octreotide scintigraphy
    Secondo Lastoria
    Division of Nuclear Medicine, National Cancer Institute Fondazione G Pascale, Naples, Italy
    Cancer 94:633-40. 2002
    ..Somatostatin receptor scintigraphy recently has been used to image immune-mediated diseases with excellent results...
  21. ncbi request reprint Oxaliplatin/rituximab combination in the treatment of intermediate-low grade non-Hodgkin's lymphoma of elderly patients
    Raffaele Addeo
    Oncology Department, S Giovanni di Dio Hospital, ASL Napoli 3, 80028 Frattaminore, Naples, Italy
    Oncol Rep 12:135-40. 2004
    ..These results demonstrate the feasibility of this schedule which offers a suitable alternative regimen to treat elderly patients with NHL and shows a good efficacy and an acceptable toxicity profile...
  22. ncbi request reprint Atypical cutaneous lymphoid hyperplasia induced by chemotherapy in a patient with advanced colon carcinoma
    Raffaele Addeo
    Department of Oncology, S Giovanni di Dio Hospital, Naples, Italy
    Clin Colorectal Cancer 6:728-30. 2007
    ..The authors postulate that chemotherapy can promote an aberrant immune response to an antigen that can be the drug itself or other self-antigens...
  23. ncbi request reprint Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women > or = 65 years of age
    Raffaele Addeo
    Oncology Unit, U O C Oncology, S Giovanni di Dio Hospital, ASL Napoli 3, Via Giovanni XXIII, 80028, Frattaminore, Naples, Italy
    Cancer Chemother Pharmacol 62:285-92. 2008
    ....
  24. ncbi request reprint The era of targeted therapies: increasing role for novel oncologic drugs in dermatology
    Liliana Montella
    Arch Dermatol 143:788-9. 2007
  25. ncbi request reprint Hemorrhagic peritoneal carcinomatosis treated with a weekly schedule of carboplatin and paclitaxel. A case report
    Liliana Montella
    Dipartimento Medico, Unita Operativa di Oncologia Medica, ULSS 17 Veneto, Montagnana Padua, Italy
    Tumori 89:336-9. 2003
    ..In our opinion, the modified schedule adopted in the case presented here may be worthwhile for future phase II studies in a selected patient population...
  26. ncbi request reprint Cetuximab is an active treatment of metastatic and chemorefractory thymoma
    Giovannella Palmieri
    Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy
    Front Biosci 12:757-61. 2007
    ..Therefore, both patients are still on therapy. This preliminary experience suggests that cetuximab may be a useful therapeutic choice in advanced pre-treated thymic tumors...
  27. ncbi request reprint Atrial fibrillation following chemotherapy for stage IIIE diffuse large B-cell gastric lymphoma in a patient with myotonic dystrophy (Steinert's disease)
    Liliana Montella
    Ann Hematol 84:192-3. 2005
    ..The cardiac toxicity intrinsically associated with the aggressive chemotherapy employed could function as a triggering factor for the arrhythmia in the predisposed myocardium of this patient...
  28. ncbi request reprint Fatal immunodeficiency in a patient with thymoma and Good's syndrome
    Liliana Montella
    Medical Oncology Unit, S Giovanni di Dio Hospital, Frattaminore, Naples, Italy
    Tumori 91:361-3. 2005
    ..The authors present the clinical history of a thymoma patient affected by fatal immunodeficiency...
  29. ncbi request reprint Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours
    Michele Caraglia
    Oncology Department, S Giovanni di Dio Hospital, ASL Napoli 3 Via Giovanni XXIII, 80028 Frattaminore, Naples, Italy
    Cancer Chemother Pharmacol 57:34-9. 2006
    ..A combination regimen of temozolomide (TMZ) and pegylated liposomal doxorubicin has been evaluated in the treatment of brain metastases from solid tumours...
  30. ncbi request reprint Thymoma followed by paroxysmal nocturnal hemoglobinuria: a unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ T lymphocytes
    Giovannella Palmieri
    Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy
    Am J Hematol 81:774-8. 2006
    ..While PNH clones have been identified in various hematological disorders, the sequential association of thymoma and PNH has been unreported so far...